Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics

    UPPSALA, Sweden, Nov. 12 /CNW/ - Beactica AB announced today that it has
entered into a drug discovery collaboration agreement with Arrow Therapeutics
Ltd (London, UK) whereby Beactica will direct its novel characterisation
technology at selected Arrow compounds against a confidential target.

    (Logo: )

    "We are very pleased to be working with Arrow" said Beactica's CEO, Dr
Per Kallblad. "The company has a world-class reputation for conducting break
through research in the antiviral field and we look forward to applying our
technology on their targets."
    CEO of Arrow Therapeutics, Dr Ken Powell, said "Working with Beactica
provides us with an opportunity to apply a new technology that has already
shown strong potential."

    About Beactica

    Beactica AB is a specialist drug discovery company, utilising its
proprietary methodologies to evaluate the biophysical interaction of molecules
in order to generate novel therapeutics. As well as building collaborations
with external companies, Beactica is progressing its own drug discovery
    For more information about Beactica, please visit

    About Arrow Therapeutics

    Arrow Therapeutics Ltd is a fully integrated pharmaceutical company,
focused exclusively on the discovery and development of novel antiviral
therapeutics in areas of significant unmet need. Established in 1998 and
acquired by AstraZeneca in February 2007, Arrow specialises in small molecule
drugs with novel mechanisms of action. The company has a number of research
and development programs, the most advanced of which target Respiratory
Syncytial Virus (RSV) and Hepatitis C Virus (HCV).
    For more information about Arrow Therapeutics, please visit

For further information:

For further information: Dr Per Kallblad, CEO Beactica,
+46(0)730-674488, or Dr Ken Powell, CEO Arrow Therapeutics, +44(0)207015-1000

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890